Developing antisense oligonucleotides from the laboratory to clinical trials

Drug Discovery Today

Volumn 1, Issue 10, 1996, Pages 415-428

  Szymkowski, David E ^a  

^a ROCHE PRODUCTS LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000140697     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(96)80008-0     Document Type: Review

References (102)

1. Stein, C.A. and Narayanan, R. (1994) Curr. Opin. Oncol. 6, 587-594
2. Crooke, S.T. (1995) Hematol. Pathol. 3, 59-72
3. Sarmiento, U.M. et al. (1994) Antisense Res. Dev. 4, 99-107
4. Sharma, H.W. and Narayanan, R. (1996) BioEssays 17, 1055-1063
5. Zon, G. (1993) in Antisense Research and Applications (Crooke, S.T. and Lebleu, B., eds), pp. 1-5, CRC Press
6. Barrett, J.C., Miller, P.S. and Ts'O, P.O.P. (1974) Biochemistry 13, 4897-4906
7. Zamecnik, P.C. and Stephenson, M.L. (1978) Proc. Natl. Acad. Sci. U. S. A. 75, 280-284
8. Stein, C.A. and Krieg, A. (1994) Antisense Res. Dev. 4, 67-70
9. Crooke, S.T. (1993) FASEB J. 7, 533-539
10. Mirabelli, C.K. and Cooke, S.T. (1993) in Antisense Research and Applications (Crooke, S.T. and Lebleu, B., eds), pp. 7-35, CRC Press
11. Mahon, F.X. et al. (1995) Exp. Hematol. 23, 1606-1611
12. Morishita, R. et al. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5855-5859
13. Sharma, H.W. et al. (1995) Anticancer Res. 15, 1857-1867
14. Bishop, J.S. et al. (1996) J. Biol. Chem. 271, 5698-5703
15. Giles, R.V. et al. (1995) Nucleic Acids Res. 23, 954-961
16. Galbraith, W.M. et al. (1994) Antisense Res. Dev. 4, 201-207
17. Cornish, K.G. et al. (1993) Pharmacol. Commun. 3, 239-247
18. Stein, C.A. (1996) Trends Biotechnol. 14, 147-149
19. Monia, B.P. et al. (1992) J. Biol. Chem. 267, 19954-19962
20. Giles, R.V. et al. (1995) Blood 86, 744-754
21. Gewirtz, A.M. (1993) Stem Cells (Dayt) 11S3, 96-103
22. Rojanasakul, Y. (1996) Adv. Drug Deliv. Rev. 18, 115-131
23. Freier, S.M. (1993) in Antisense Research and Applications (Crooke, S.T. and Lebleu, B. eds), pp. 67-82, CRC Press
24. González, C. et al. (1995) Biochemistry 34, 4969-4982
25. Wagner, R.W. et al. (1996) Nat. Biotechnol. 14, 840-844
26. Cload, S.T. and Schepartz, A. (1994) J. Am. Chem. Soc. 116, 437-442
27. Moulds, C. et al. (1995) Biochemistry 34, 5044-5053
28. Hodges, D. and Crooke, S.T. (1995) Mol. Pharmacol. 48, 905-918
29. Khaled, Z. et al. (1996) Nucleic Acids Res. 24, 737-745
30. Dean, N.M. and McKay, R. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11762-11766
31. Monia, B.P. et al. (1996) Nat. Med. 2, 668-675
32. Simons, M. et al. (1992) Nature 359, 67-70
33. Azad, R.F. et al. (1995) Antiviral Res. 28, 101-111
34. Zhang, R. et al. (1995) Clin. Pharmacol. Ther. 58, 44-53
35. Crooke, S.T. et al. (1994) Clin. Pharmacol. Ther. 56, 641-646
36. Maltese, J.Y. et al. (1995) Nucleic Acids Res. 23, 1146-1151
37. Bayever, E. et al. (1993) Antisense Res. Dev. 3, 383-390
38. Ratajczak, M.Z. et al. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 11823-11827
39. Bishop, M.R. et al. (1996) J. Clin. Oncol. 14, 1320-1326
40. Bennett, C.F. et al. (1994) J. Immunol. 152, 3530-3540
41. Bennett, M.R. and Schwartz, S.M. (1995) Circulation 92, 1981-1993
42. Kulka, M. et al. (1993) Antiviral Res. 20, 115-130
43. Moriya, K. et al. (1996) Biochem. Biophys. Res. Commun. 218, 217-223
44. Alt, M. et al. (1995) Hepatology 22, 707-717
45. Pagano, J.S. et al. (1992) Ann. New York Acad. Sci. 660, 107-116
46. Zamecnik, P.C. and Agrawal, S. (1991) Nucleic Acids Symp. Ser. 20, 127-131
47. Maitra, R.K. et al. (1995) J. Biol. Chem. 270, 15071-15075
48. Yuan, Y., Hwang, E.S. and Altman, S. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 8006-8010
49. Wang, G. et al. (1995) Mol. Cell. Biol. 15, 1759-1768
50. Matsukura, M. et al. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 7706-7710
51. Srinivasan, S.K., Tewary, H.K. and Iversen, P.L. (1995) Antisense Res. Dev. 5, 131-139
52. Agrawal, S., Rustagi, P.K. and Shaw, D.R. (1995) Toxicol. Lett. 82-83, 431-434
53. Shoji, Y. et al. (1991) Nucleic Acta Res. 19, 5543-5550
54. Gewirtz, A.M., Stein, CA and Glazer, P.M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 3161-3163
55. Altmann, K-H. et al. (1996) Chimia 50, 168-176
56. Krieg, A.M. et al. (1995) Nature 374, 546-549
57. Agrawal, S. et al. (1995) Clin. Pharmacokin. 28, 7-16
58. Zhang, R. et al. (1995) Biochem. Pharmacol. 50, 545-556
59. Saijo, Y. et al. (1994) Oncol. Res. Int. J. 6, 243-249
60. Vlassov, V.V. et al. (1995) in Delivery Strategies for Antisense Oligonucleotide Therapeutics (Akhtar, S., ed.), pp. 71-83, CRC Press
61. Crooke, S.T. et al. (1996) J. Pharmacol. Exp. Ther. 277, 923-937
62. Plenat, F. et al. (1995) Am. J. Pathol. 147, 124-135
63. Black, L.E. et al. (1994) Antisense Res. Dev. 4, 299-301
64. Branda, R.F. et al. (1993) Biochem. Pharmacol. 45, 2037-2043
65. Crooke, S.T. (1993) Antisense Res. Dev. 3, 310-316
66. Gaudette, M.F. et al (1993) Antisense Res. Dev. 3, 391-397
67. Cook, P.D. (1993) in Antisense Research and Applications (Crooke, S.T. and Lebleu, B., eds), pp. 149-187, CRC Press
68. Campbell, J.M., Bacon, T.A. and Wickstrom, E. (1990) J. Biochem. Biophys. Methods 20, 259-267
69. Tang, J.Y., Temsamani, J. and Agrawal, S. (1993) Nucleic Acids Res. 21, 2729-2735
70. Egholm, M. et al. (1993) Naturel, 566-568
71. Brown, S.C. et al. (1994) Science 265, 777-780
72. Bonham, M.A. et al. (1995) Nucleic Acids Res. 23, 1197-1203
73. McKay, R.A. et al. (1996) Nucleic Acids Res. 24, 411-417
74. Crooke, R.M. (1993) in Antisense Research and Applications (Crooke, S.T. and Lebleu, B., eds), pp. 427-449, CRC Press
75. Agrawal, S. et al. (1995) Biochem. Pharmacol. 50, 571-576
76. Thierry, A.R. and Takle, G.B. (1995) in Delivery Strategies for Antisense Oligonucleotide Therapeutics (Akhtar, S., ed.), pp. 199-221, CRC Press
77. Bennett, C.F. (1995) in Delivery Strategies for Antisense Oligonucleotide Therapeutics (Akhtar, S., ed.), pp. 223-232, CRC Press
78. Oberhauser, B., Plank, C. and Wagner, E. (1995) in Delivery Strategies for Antisense Oligonucleotide Therapeutics (Akhtar, S., ed.), pp. 247-266, CRC Press
79. Zelphati, O. et al. (1994) Nucleic Acta Res. 22, 4307-4314
80. Hughes, J.A. et al. (1996) Pharm. Res. 13, 404-410
81. Lewis, J.G. et al. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 3176-3181
82. Gooden, C.S.R. and Epenetos, A.A. (1995) in Delivery Strategies for Antisense Oligonucleotide Therapeutics (Akhtar, S., ed.), pp. 283-293, CRC Press
83. Carmichael, E.P. et al. (1995) in Delivery Strategies for Antisense Oligonucleotide Therapeutics (Akhtar, S., ed.), pp. 267-282, CRC Press
84. Citro, G. et al. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 7031-7035
85. Wang, S. et al. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3318-3322
86. Letsinger, R.L. et al. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 6553-6556
87. Pertmer, T.M. et al. (1995) Vaccine 13, 1427-1430
88. Chavany, C. et al. (1994) Pharm. Res. 11, 1370-1378
89. Bergot, B.J. et al. (1993) Nucleic Acta Symp. Ser. 29, 57
90. Miller, P.S. and Ts'O, P.O.P. (1985) US Patent 4,511,713
91. Sanghvi, Y.S. and Cook, P.D. (1995) US Patent 5,386,023
92. Agrawal, S. et al. (1993) US Patent 5,194,428
93. Gewirtz, A.M. and Calabretta, B. (1992) US Patent 5,098,890
94. Black, L.E. et al. (1993) Antisense Res. Dev. 3, 399-404
95. Wang, Q. and Marini, J.C. (1996) J. Clin. Invest. 97, 448-454
96. Burgess, T.L. et al. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 4051-4055
97. Offensperger, W-B., Blum, H.E. and Gerok, W. (1995) Intervirology 38, 113-119
98. Kulka, M. et al. (1994) Antimicrob. Agents Chemother. 38, 675-780
99. Wagner, R.W. (1995) Nat. Med. 1, 1116-1118
100. Miller, P.S. et al. (1993) in Antisense Research and Applications (Crooke, S.T. and Lebleu, B., eds), pp. 189-203, CRC Press
101. Sproate, B.S. and Lamond, A.J. (1993) in Antisense Research and Applications (Crooke, S.T. and Lebleu, B., eds), pp. 351-362, CRC Press
102. Bellon, L. et al. (1993) Nucleic Acta Res. 21, 1587-1593